Gunderson-Led Theseus Pharma To Launch $125M IPO
Theseus Pharmaceuticals, which develops treatment for cancer patients, announced terms Thursday for a roughly $125 million initial public offering led by Gunderson Dettmer and underwriters counsel WilmerHale....To view the full article, register now.
Already a subscriber? Click here to view full article